𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparing costs and effectiveness of different starting points for highly active antiretroviral therapy in HIV-positive patients

✍ Scribed by Monica Merito; Patrizio Pezzotti; for the ICONA Study Group

Publisher
Springer
Year
2006
Tongue
French
Weight
802 KB
Volume
7
Category
Article
ISSN
1618-7598

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased detection of HBV DNA in HBsAg-
Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital
✍ Azwidowi Lukhwareni; Rosemary J. Burnett; S. Gloria Selabe; M. Olga Mzileni; M. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract This retrospective study investigated the prevalence of hepatitis B virus (HBV) in 192 stored sera from human immunodeficiency virus (HIV) positive South African patients initiating antiretroviral therapy (ART), and explored the implications of HBV–HIV co‐infection on laboratory diagnos

Quantitation of cytomegalovirus (CMV) DN
Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy
✍ Karine Gourlain; Dominique Salmon; Elyanne Gault; Catherine Leport; Christine Ka 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract In HIV‐infected patients treated with highly active antiretroviral therapy (HAART) included in the Predivir cohort, we have evaluated the usefulness of CMV DNA quantitation by a TaqMan^®^ PCR assay from peripheral blood leukocytes (PBLs) to predict CMV disease occurrence. In parallel wi